Literature DB >> 24458895

Predictive value of upper-limb accelerometry in acute stroke with hemiparesis.

Nick Gebruers1, Steven Truijen, Sebastiaan Engelborghs, Peter P De Deyn.   

Abstract

Few studies have investigated how well early activity measurements by accelerometers predict recovery after stroke. First, we assessed the predictive value of accelerometer-based measurements of upper-limb activity in patients with acute stroke with a hemiplegic arm. Second, we established the difference in arm activity between hospitalized stroke and nonstroke patients. In total, 129 patients with acute stroke and 19 controls participated. Activity of the upper limbs was monitored for 48 h, and these data were used to determine the predictive value of the activity variables compared with the modified Rankin Scale (mRS), which was assessed at 3 mo poststroke onset. The sensitivity and specificity in relation to the mRS were 0.80 and 0.77, respectively, for the activity of impaired arm (AIA) and 0.85 and 0.75, respectively, for the ratio variable calculated by dividing the AIA by the activity of the nonimpaired arm. The corresponding cutoff values were 597,546 counts for AIA and 0.33 for the ratio. The predictive value of AIA combined with age was 85% to the disability status defined as an mRS score of 2 or less.

Entities:  

Keywords:  accelerometry; activity measure; ambulatory monitoring; hemiparesis; modified Rankin Scale; paresis; prediction; recovery; stroke; upper limb

Mesh:

Year:  2013        PMID: 24458895     DOI: 10.1682/JRRD.2012.09.0166

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  9 in total

1.  Digital Phenotyping in Clinical Neurology.

Authors:  Anoopum S Gupta
Journal:  Semin Neurol       Date:  2022-01-11       Impact factor: 3.212

2.  An upper body garment with integrated sensors for people with neurological disorders - early development and evaluation.

Authors:  Margit Alt Murphy; Filip Bergquist; Bengt Hagström; Niina Hernández; Dongni Johansson; Fredrik Ohlsson; Leif Sandsjö; Jan Wipenmyr; Kristina Malmgren
Journal:  BMC Biomed Eng       Date:  2019-01-30

3.  Suitability of accelerometry as an objective measure for upper extremity use in stroke patients.

Authors:  Anne-Lisa Heye; Christine Kersting; Malte Kneer; Anne Barzel
Journal:  BMC Neurol       Date:  2022-06-15       Impact factor: 2.903

Review 4.  Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.

Authors:  Valerie A J Block; Erica Pitsch; Peggy Tahir; Bruce A C Cree; Diane D Allen; Jeffrey M Gelfand
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

5.  Hemispheric asymmetry in myelin after stroke is related to motor impairment and function.

Authors:  Bimal Lakhani; Kathryn S Hayward; Lara A Boyd
Journal:  Neuroimage Clin       Date:  2017-01-16       Impact factor: 4.881

Review 6.  Wearable sensors for clinical applications in epilepsy, Parkinson's disease, and stroke: a mixed-methods systematic review.

Authors:  Dongni Johansson; Kristina Malmgren; Margit Alt Murphy
Journal:  J Neurol       Date:  2018-02-09       Impact factor: 4.849

7.  Actigraphic measurement of the upper limbs movements in acute stroke patients.

Authors:  Chiara Iacovelli; Pietro Caliandro; Marco Rabuffetti; Luca Padua; Chiara Simbolotti; Giuseppe Reale; Maurizio Ferrarin; Paolo Maria Rossini
Journal:  J Neuroeng Rehabil       Date:  2019-12-04       Impact factor: 4.262

8.  Actigraphic Measurement of the Upper Limbs for the Prediction of Ischemic Stroke Prognosis: An Observational Study.

Authors:  Giuseppe Reale; Silvia Giovannini; Chiara Iacovelli; Stefano Filippo Castiglia; Pietro Picerno; Aurelia Zauli; Marco Rabuffetti; Maurizio Ferrarin; Giulio Maccauro; Pietro Caliandro
Journal:  Sensors (Basel)       Date:  2021-04-02       Impact factor: 3.576

9.  Arm impairment and walking speed explain real-life activity of the affected arm and leg after stroke.

Authors:  Sofi A Andersson; Anna Danielsson; Fredrik Ohlsson; Jan Wipenmyr; Margit Alt Murphy
Journal:  J Rehabil Med       Date:  2021-06-23       Impact factor: 2.912

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.